| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/04/2009 | WO2009022157A3 Peptide with improved solubility |
| 06/04/2009 | WO2009022155A3 Peptide with reduced dimer formation |
| 06/04/2009 | WO2009022154A3 Peptide with multiple epitopes |
| 06/04/2009 | WO2009009670A4 Apparatus and method for harvesting biologics from eggs |
| 06/04/2009 | WO2009006420A3 Vaccine production for pathogenic bird viral diseases |
| 06/04/2009 | WO2008116078A3 Stimulation of an immune response by cationic lipids |
| 06/04/2009 | WO2008045346A3 Recombinant modified vaccinia ankara encoding a her-2 antigen for use in treating cancer |
| 06/04/2009 | WO2007044731A3 Recombinant proteins from filoviruses and their use |
| 06/04/2009 | WO2007011827A3 G1 cytostatic agents enhancing antiviral activity of viral-envelope targeting drugs and antibodies |
| 06/04/2009 | WO2007009065A3 Methods of treating autoimmune disease using humanized anti-cd16a antibodies |
| 06/04/2009 | WO2006110831A3 Method of inducing neutralizing antibodies to human immunodeficiency virus |
| 06/04/2009 | WO2004063335A3 TNF-α BINDING MOLECULES |
| 06/04/2009 | US20090144839 Methods and compositions for detecting and treating retinal diseases |
| 06/04/2009 | US20090143997 Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1 |
| 06/04/2009 | US20090143762 Methods and Compositions for Enhancing the Viability Of Microneedle Pores |
| 06/04/2009 | US20090143724 Microprojection Array Immunization Patch and Method |
| 06/04/2009 | US20090143568 Recombinant gelatins |
| 06/04/2009 | US20090143291 Tumor antigen based on products of the tumor suppressor gene wt1 |
| 06/04/2009 | US20090143289 Orthopoxvirus vectors, genes and products thereof |
| 06/04/2009 | US20090142833 Pine Cone Extracts and Uses Thereof |
| 06/04/2009 | US20090142794 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142780 Methods of donor specific crossmatching |
| 06/04/2009 | US20090142778 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| 06/04/2009 | US20090142405 Bioactive agent, a low molecular weight chitosan, and a negatively charged third component; the chitosan dominates on the nanoparticle surface; enhanced permeability for paracellular drug delivery; chewable composition |
| 06/04/2009 | US20090142399 Dispersant agent for sustained-release preparations |
| 06/04/2009 | US20090142377 Immunogenic compositions |
| 06/04/2009 | US20090142376 Chlamydia polypeptides and corresponding dna fragments and uses thereof |
| 06/04/2009 | US20090142375 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses madiated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 06/04/2009 | US20090142374 Composition for immunostimulation |
| 06/04/2009 | US20090142373 Immunizing Against HIV Infection |
| 06/04/2009 | US20090142372 Therapeutic composition for use in the prevention and treatment of bone metastases |
| 06/04/2009 | US20090142371 Hiv recombinant vaccine |
| 06/04/2009 | US20090142368 Chemically Programmable Immunity |
| 06/04/2009 | US20090142367 Yeast-Based Vaccines As Immunotherapy |
| 06/04/2009 | US20090142366 Yeast-Based Vaccines As Immunotherapy |
| 06/04/2009 | US20090142365 Compositions and methods for using ca9 protein to stimulate an immune response |
| 06/04/2009 | US20090142364 Method for finding novel peptide immunostimulatory adjuvants, compositions and methods of use |
| 06/04/2009 | US20090142363 Cytotoxic t-cell epitope peptide and use thereof |
| 06/04/2009 | US20090142362 Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP) |
| 06/04/2009 | US20090142361 Drug conjugate composition |
| 06/04/2009 | US20090142360 Use of ferritin to treat iron deficiency disorders |
| 06/04/2009 | US20090142359 Anti-Her2 antibodies which induce apoptosis in Her2 expressing cells; treating cancer by Her2 overexpression using the antibodies |
| 06/04/2009 | US20090142358 Human antibodies specific to kdr and uses thereof |
| 06/04/2009 | US20090142357 Specific Depletion of CD4+ T Cells |
| 06/04/2009 | US20090142356 Pharmaceutical Composition of F(ab')2 Antibody Fragments and a Process for the Preparation Thereof |
| 06/04/2009 | US20090142355 Diagnosis and treatment of type 1 diabetes |
| 06/04/2009 | US20090142354 Human antibodies to human delta like ligand 4 |
| 06/04/2009 | US20090142353 Human Tumor Necrosis Factor Receptor TR17 |
| 06/04/2009 | US20090142352 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 06/04/2009 | US20090142351 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof |
| 06/04/2009 | US20090142350 Pancreatic Cancer Genes |
| 06/04/2009 | US20090142349 CD19 Antibodies And Their uses |
| 06/04/2009 | US20090142348 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 06/04/2009 | US20090142347 Tissue-Nonspecific Alkaline Phosphatase (TNAP): a Therapeutic Target for Arterial Calcification |
| 06/04/2009 | US20090142346 Preventive/Remedy for Cancer |
| 06/04/2009 | US20090142345 Prophylactic/therapeutic agent for cancer |
| 06/04/2009 | US20090142344 Breast cancer related gene znfn3a1 |
| 06/04/2009 | US20090142343 Anti-VEGF antibodies |
| 06/04/2009 | US20090142342 B7-h4 receptor agonist compositions and methods for treating inflammation and auto-immune diseases |
| 06/04/2009 | US20090142341 Mutated pseudomonas exotoxins with reduced antigenicity |
| 06/04/2009 | US20090142340 Optimized Fc Variants and Methods for Their Generation |
| 06/04/2009 | US20090142339 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor |
| 06/04/2009 | US20090142338 Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions |
| 06/04/2009 | US20090142337 Pharmaceutical Combinations of Diazole Derivatives for Cancer Treatment |
| 06/04/2009 | US20090142336 Metabolic regulators and uses thereof |
| 06/04/2009 | US20090142335 Methods of diagnosis and treatment of metabolic disorders |
| 06/04/2009 | US20090142334 DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE |
| 06/04/2009 | US20090142333 Activin-actriia antagonists and uses for promoting bone growth in cancer patients |
| 06/04/2009 | US20090142332 Identification of Biomarkers by Serum Protein Profiling |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142327 Novel Class of Therapeutic Protein Based Molecules |
| 06/04/2009 | US20090142300 Compositions and methods related to toll-like receptor-3 |
| 06/04/2009 | US20090142297 5-substituted isoindoline compounds |
| 06/04/2009 | US20090142296 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 06/04/2009 | US20090142294 Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes |
| 06/04/2009 | US20090142270 Prevention and treatment of cerebral amyloid angiopathy |
| 06/04/2009 | US20090142263 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 06/04/2009 | US20090142262 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Prostate Cancer |
| 06/04/2009 | US20090142261 EPHB3-Specific Antibody and Uses Thereof |
| 06/04/2009 | CA2802984A1 Use of eph-b4 and ephrin-a1 for predicting negative physiological response to the treatment with erythropoietin |
| 06/04/2009 | CA2707190A1 Novel wheat allergens |
| 06/04/2009 | CA2707107A1 Therapeutic targets and medicaments involving p230/golgin-245 |
| 06/04/2009 | CA2706835A1 Stat3 epitope peptides |
| 06/04/2009 | CA2706633A1 Novel cancer-associated antibody and antigen |
| 06/04/2009 | CA2706627A1 A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
| 06/04/2009 | CA2706619A1 Vaccination with multiple clades of h5 influenza a virus |
| 06/04/2009 | CA2706603A1 Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 06/04/2009 | CA2706583A1 Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof |
| 06/04/2009 | CA2706479A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 06/04/2009 | CA2706476A1 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis |
| 06/04/2009 | CA2706419A1 Antigen-binding constructs |
| 06/04/2009 | CA2706415A1 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 06/04/2009 | CA2706300A1 Human monoclonal nicotine specific antibodies |
| 06/04/2009 | CA2706014A1 Carrier particle for a microorganism or subunit thereof, pharmaceutical composition comprising such particles, method for preparation of this composition and its use in the treatment of animals |
| 06/04/2009 | CA2705879A1 Wise binding agents and epitopes |
| 06/03/2009 | EP2065468A1 Modifications of hiv env enhance immunogenicity for genetic immunization |
| 06/03/2009 | EP2065467A2 Anti-interferon-alpha antibodies |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |